Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): Evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 451-458

  Khanna, Rajiv ^a   Burrows, Scott R ^a   Nicholls, John ^b   Poulsen, Leith M ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytotoxic T lymphocyte; Epitope; Epstein Barr virus; HLA restriction; Latent membrane protein 1

Indexed keywords

EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; HLA A2 ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HLA SYSTEM; ONCOGENE; PRIORITY JOURNAL;

ALLELES; BURKITT LYMPHOMA; CELL LINE, TRANSFORMED; EPITOPES, T-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HLA-A2 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; ONCOGENE PROTEINS, VIRAL; PEPTIDE FRAGMENTS; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0031936036     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U     Document Type: Article

References (22)

1. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H. and Rickinson, A. B., Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 1987. 6: 2743-2751.
2. Rooney, C. M., Rowe, M., Wallace, L. E. and Rickinson, A. B., Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance. Nature 1985. 317: 629-631.
3. Khanna, R., Burrows, S. R. and Moss, D. J., Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 1995. 59: 387-405.
4. Fahraeus, R., Rymo, L., Rhim, J. S. and Klein, G., Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 1990. 345: 447-449.
5. Young, L. S., Dawson, C. W., Clark, D., Rupani, H., Busson, P., Tursz, T., Johnson, A. and Rickinson, A. B., Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J. Gen. Virol. 1988. 69: 1051-1065.
6. Wang, D., Liebowitz, D. and Kieff, E., An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985. 43: 831-840.
7. Wang, D., Liebowitz, D. and Kieff, E., The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J. Virol. 1988. 62: 2337-2346.
8. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E. and Moss, D. J., Localization of Epstein-Barr virus cytotoxic T-cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 1992. 176: 169-176.
9. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. and Rickinson, A. B., Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J. Exp. Med. 1992. 176: 157-168.
10. Parker, K. C., Bednarek, M. A. and Coligan, J. E., Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 1994. 152: 163-175.
11. Burrows, S. R., Suhrbier, A., Khanna, R. and Moss, D. J., Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology 1992. 76: 174-175.
12. Del Guercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M., Kubo, R. T. and Sette, A., Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 1995. 154: 685-693.
13. Khanna, R., Burrows, S. R., Suhrbier, A., Jacob, C. A., Griffin, H., Misko, I. S., Sculley, T. B., Rowe, M., Rickinson, A. B. and Moss, D. J., EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. J. Immunol. 1993. 150: 5154-5162.
14. Krausa, P., Brywka, M., Savage, D., Hui, K. M., Bunce, M., Ngai, J. L., Teo, D. L., Ong, Y. W., Barouch, D. and Allsop, C. E., Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 1995. 45: 223-231.
15. Salter, R. D. and Cresswell, P., Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. EMBO J. 1986. 5: 943-949.
16. Khanna, R., Jacob, C. A., Burrows, S. R. and Moss, D. J., Presentation of endogenous viral peptide epitopes by anti-CD40 stimulated human B cells following recombinant vaccinia infection. J. Immunol. Methods 1993. 164: 41-49.
17. Wang J. H., Yan, Y. W., Garrett, T. P., Liu, J. H., Rodgers, D. W., Garlick, R. L., Tarr, G. E., Husain, Y., Reinherz, E. L. and Harrison, S. C., Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 1990. 348: 411-418.
18. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E. and Rickinson, A. B., Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991. 65: 1107-1115.
19. Burrows, J. M., Burrows, S. R., Poulsen, L. M., Sculley, T. B., Moss, D. J. and Khanna, R., Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J. Virol. 1996. 70: 2490-2496.
20. Moss, D. J., Misko, I. S., Burrows, S. R., Burman, K., McCarthy, R. and Sculley, T. B., Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants. Nature 1988. 331: 719-721.
21. Khanna, R., Jacob, C. A., Burrows, S. R., Kurilla, M. G., Kieff, E., Misko, I. S. and Moss, D. J., Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T-cells. Immunology 1991. 74: 504-510.
22. Fazekas de St Groth, S., The evaluation of limiting dilution assays. J. Immunol. Methods 1982. 49: R11-23.